Article
Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
Journal of thrombosis and haemostasis : JTH - 1 Apr 2016
Marar T T, Boffa M B
Abstract excerpt
BACKGROUND: Thrombin-activatable fibrinolysis inhibitor (TAFI) is a human plasma zymogen that provides a molecular connection between coagulation and fibrinolysis. TAFI is activated through proteolytic cleavage by thrombin, thrombin in complex with the endothelial cell cofactor thrombomodulin (TM) or plasmin. Evidence from several studies suggests that TM and TAFI make direct contact at sites remote from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
